References
- Homma H, Yamanaka A, Tanimoo S, Tamura M, Chijimatsu Y, Kira S, Izumi T. Diffuse panbronchitis: a disease of the transitional zone of the lung. Chest 1983; 83: 27–69.
- Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M. Improvement of survival in patients with diffuse panbronchitis treated with low-dose erythromycin. Am J Respir Crit Care Med 1998; 157: 1829–32.
- Kadota J, Mukae H, Fujii T, Seki M, Tomono K, Kohno S. Clinical similarities and differences between human T-cell lymphotropic virus type 1-associated bronchiolitis and diffuse panbronchiolitis. Chest 2004; 125: 1239–47.
- Sugiyama Y, Kudoh S, Maeda H, Suzaki H, Takaku F. Analysis of HLA antigen in patients with diffuse panbronchitis. Am Rev Respir Dis 1990; 141: 1459–62.
- Kudou S, Uetake T, Hagiwara K, Hirayama M, Kimura H, Sugiyama Y. Clinical effect of low dose long-term erythromycin chemotherapy of diffuse panbronchitis. Jpn J Thorac Dis 1987; 25: 632–42.
- Sugimoto M, Nakashima H, Watanabe S, Uyama E, Tanaka F, Ando M, et al. T-lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet 1987; 21: 1220.
- Couderc LJ, Caubarrere I, Venet A, Magdeleine J, Jouanelle A, Danon F, et al. Bronchoalveolar lymphocytosis in patients with tropical spastic paraparesis associated with human T-cell lymphotropic virus type 1 (HTLV-1). Clinical, immunologic, and cytologic studies. Ann Intern Med 1988; 109: 625–8.
- Koga T. Neutrophilia and high level of interleukin 8 in the bronchoalveolar lavage fluid of diffuse panbronchitis. Kurume Med J 1993; 40: 139–46.
- Santos SB, Porto AF, Muniz AL, de Jesus AR, Magalhaes E, Melo A, et al. Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers. BMC Infect Dis 2004; 4: 7–14.
- Taylor GP, Tosswill JH, Matutes E, Daenke S, Hall S, Bain BJ, et al. Prospective study of HTLV-I infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr 1999; 22: 92–100.
- Lagrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-1 infection. Lancet 1990; 336: 1345–7.
- Carvalho EM, Bacellar O, Porto AF, Braga S, Galvao-Castro B, Neva F. Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors. J Acquir Immune Defic Syndr 2001; 27: 1–6.
- Tachibana N, Okayama A, Ishizaki J, Yokota T, Shishime E, Murai K, et al. Suppression of tuberculin skin reaction in healthy HTLV-1 carriers from Japan. Int J Cancer 1988; 42: 829–31.
- Tanaka Y, Shirakawa F, Oda S, Chiba S, Suzuki H, Eto S, et al. Effect of immunosuppressive factors produced by T-cell leukemia cells on B-cell responses. Jpn J Cancer Res 1987; 78: 1390–9.
- de Shazo R, Chadha N, Morgan JE, Shorty VJ, Rangan SR, Kalyanaraman VS, et al. Immunologic assessment of a cluster of asymptomatic HTLV-1-infected individuals in New Orleans. Am J Med 1989; 86: 65–70.
- Shaw GM, Broder S, Essex M, Gallo R. Human T-cell leukemia virus: its discovery and role in leukemogenesis and immunosuppression. Adv Intern Med 1984; 30: 1–27.